Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

3.19
Delayed Data
As of Sep 25
 +0.04 / +1.27%
Today’s Change
1.97
Today|||52-Week Range
5.78
+47.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues23.4M10.7M17.9M27.1M
 
 
 
 
 
Cost of Goods Sold14.8M7.3M11.2M19.8M
 
 
 
 
 
Depreciation And Amortization606.0K631.0K613.0K642.0K
 
 
 
 
 
 
Operating ExpensesGross Income7.9M2.8M6.1M6.6M
 
 
 
 
 
General Expenses12.0M10.6M11.4M7.9M
 
 
 
 
 
Research And Development7.0M6.0M6.7M3.6M
 
 
 
 
 
Total Operating Expenses27.4M18.5M23.2M28.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.1M-7.8M-5.3M-1.2M
 
 
 
 
 
Interest Expense On Debt--2.0K5.0K3.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.1M-7.8M-5.3M-1.2M
 
 
 
 
 
Preferred Dividend-1.4M-1.4M-1.4M-1.4M
 
 
 
 
 
Net Income-4.1M-7.8M-5.3M-1.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.0M37.3M42.1M44.8M
 
 
 
 
 
Shares To Calculate EPS Diluted35.0M37.3M42.1M44.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14-$0.28-$1.12-$0.06
 
 
 
 
 
EPS Diluted-$0.14-$0.28-$0.16-$0.06